Profile
ADVB DHR-PB TMO DHR IDXX A
Company Name Advanced Biomed Inc. Common Stock Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $36.14M $916.76B $160.15B $141.09B $35.45B $30.30B
Employees 0.04K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Dr. Yi Lu Ph.D. Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
ADVB DHR-PB TMO DHR IDXX A
Quant Rating Score 5 3 3 3 3
Quant Rating Strong Buy Neutral Neutral Neutral Neutral
Trading
ADVB DHR-PB TMO DHR IDXX A
Last Close $1.81 $1261.26 $424.24 $197.14 $437.44 $106.28
High 52 $4 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 - $1261.26 $419.59 $174.64 $361.04 $99.29
Price vs. 52 Week High -54.75 % 0 % -32.04 % -29.78 % -20.25 % -31.27 %
Price vs. 52 Week Low 0 % 0 % 1.11 % 12.88 % 21.16 % 7.04 %
Total Return
ADVB DHR-PB TMO DHR IDXX A
1 Month Return -54.29 % 0 % -17.41 % -6.31 % 4.72 % -11.36 %
3 Month Return 0 % 0 % -26.2 % -19.8 % 0.48 % -29.82 %
6 Month Return 0 % 0 % -23.47 % -19.66 % -3.09 % -18.37 %
9 Month Return 0 % 0 % -30.12 % -28.03 % -6.87 % -22.6 %
YTD Return 0 % 0 % -18.45 % -14.12 % 5.8 % -20.89 %
1 Year Return 0 % 0 % -26.04 % -20.05 % -12.39 % -22.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADVB DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.38 % 0.57 % - 0.91 %
Dividend Paid and Capex Coverage Ration (TTM) - 2.93 % 4.05 % 2.93 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Profitability
ADVB DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 59.74 % 41.74 % 59.74 % 61.08 % 53.97 %
Return on Assets TTM 4.76 % 6.58 % 4.76 % 26.96 % 10.57 %
Return on Equity TTM 7.47 % 13.34 % 7.47 % 55.82 % 20.95 %
Return on Capital Employed TTM 6.66 % 8.53 % 6.66 % 50.78 % 14.73 %
Net Income Per EBT TTM 83.59 % 92.18 % 83.59 % 80 % 84.78 %
EBT Per Ebit TTM 93.35 % 96.45 % 93.35 % 98.21 % 100.34 %
EBIT Per Revenue TTM 20.26 % 17.08 % 20.26 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Receivables Turnover TTM 6.79 5.07 6.79 6.94 4.92
Payables Turnover TTM 5.57 - 5.57 13.28 5.5
Inventory Turnover TTM 3.79 4.78 3.79 3.97 3.02
Fixed Asset Turnover TTM 466.14 % 459.74 % 466.14 % 470 % 359.75 %
Asset Turnover TTM 30.11 % 43.31 % 30.11 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM 8.72 21.53 8.72 11.29 5.95
Free Cash Flow Per Share TTM 6.84 17.79 6.84 9.7 4.94
Cash Per Share TTM 278.24 % 1573.28 % 278.24 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM 26.23 % 18.97 % 26.23 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.46 % 82.61 % 78.46 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM 37.92 % 23.81 % 37.92 % 94.13 % 50.46 %
Price To Free Cash Flows Ratio TTM 28.68 23.82 28.78 44.42 21.51
Price To Operating Cash Flows Ratio TTM 22.53 19.7 22.6 38.75 17.85
Price Cash Flow Ratio TTM 22.53 19.7 22.6 38.75 17.85
Income Statement (TTM)
ADVB DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $18.11B $14.21B $2.38B $3.54B
Gross Profit Ratio 0% 59.5% 42.23% 59.5% 61.04% 54.3%
EBITDA $-0B $4.86B $11.54B $4.86B $1.27B $1.49B
Net Income $-0B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -0.13 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
ADVB DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
ADVB DHR-PB TMO DHR IDXX A
Net Income $-0B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 106.28
ACRS Aclaris Therapeutics, Inc. 1.34
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8471
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.539
BIAF bioAffinity Technologies, Inc. 0.499
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 4.3
BNR Burning Rock Biotech Limited 2.84
CDNA CareDx, Inc 18.48
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 114.66
CSTL Castle Biosciences, Inc. 20.63
DGX Quest Diagnostics Incorporated 173.76
DHR Danaher Corporation 197.14
Unlock